Substrate-Enzyme Interactions in Intramembrane Proteolysis: γ-Secretase as the Prototype
Xinyue Liu1, Jing Zhao1, Yingkai Zhang2
1Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, United States.
Frontiers in Molecular Neuroscience
|June 9, 2020
Summary
Intramembrane-cleaving proteases like presenilin within the gamma-secretase complex cleave membrane proteins. New structural insights reveal substrate unwinding and beta-sheet formation, but key questions on substrate recruitment and product release remain for Alzheimer's disease drug discovery.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Intramembrane-cleaving proteases (I-CLiPs) release bioactive fragments crucial for physiological and pathological processes.
- Presenilin, the catalytic subunit of the gamma-secretase (GS) complex, cleaves key substrates like amyloid precursor protein (APP) and Notch.
- Dysregulation of GS activity is implicated in Alzheimer's disease (AD) pathogenesis.
Purpose of the Study:
- To elucidate the structural mechanisms of substrate recognition and cleavage by the gamma-secretase complex.
- To provide atomic-level insights into presenilin's role in intramembrane proteolysis.
- To identify potential targets for therapeutic intervention in Alzheimer's disease.
Main Methods:
- Recent cryo-electron microscopy (cryo-EM) studies of the gamma-secretase complex.
- Structural analysis of presenilin and its interaction with membrane protein substrates.
- Biochemical and biophysical approaches to study enzyme-substrate dynamics.
Main Results:
- Cryo-EM structures reveal dynamic presenilin transmembrane helices (TM 2 and 6).
- Substrate binding induces unwinding of the C-terminal transmembrane helix, forming an intermolecular beta-sheet with presenilin.
- This conformational change exposes the scissile peptide bond for hydrolysis.
Conclusions:
- The structural findings provide a mechanistic basis for gamma-secretase-mediated intramembrane proteolysis.
- Significant questions remain regarding substrate recruitment, translocation, catalytic water coordination, and product release.
- Understanding these mechanisms is critical for developing targeted therapies for Alzheimer's disease.
More Related Videos
Related Concept Videos
Membrane Asymmetry Regulating Transporters
6.7K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
6.7K
GPI Anchoring of Proteins in the ER Membrane
5.1K
GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
5.1K
The Proteasome
9.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.9K
The Proteasome
1.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.5K
Enzymes
91.8K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
91.8K
The Proteasome Structure
1.4K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.4K


